{"id":101508,"date":"2023-06-27T10:58:28","date_gmt":"2023-06-27T08:58:28","guid":{"rendered":"https:\/\/test.lab.cor2ed.com\/cms\/?post_type=programmes&p=101508"},"modified":"2024-10-25T13:40:32","modified_gmt":"2024-10-25T11:40:32","slug":"primary-biliary-cholangitis-highlights-easl-2023","status":"publish","type":"programmes","link":"https:\/\/test.lab.cor2ed.com\/cms\/n-connect\/programmes\/primary-biliary-cholangitis-highlights-easl-2023\/","title":{"rendered":"Primary Biliary Cholangitis Highlights from EASL 2023 – Episode 1"},"content":{"rendered":"

In these two podcasts, medical experts and a patient representative share their perspectives on new Primary Biliary Cholangitis (PBC) data from EASL 2023.<\/p>\n

In podcast 1, physicians Dr Emma Culver<\/strong> and Prof. Gideon Hirschfield<\/strong> discuss the evidence of cancer risk associated with PBC, how liver stiffness progression is associated with prognosis; and outcomes and response prediction in second-line therapy.<\/p>\n

In podcast 2, CEO of the PBC Foundation, Robert Mitchell-Thain<\/strong>, and autoimmune specialist nurse Kath Houghton<\/strong> explore the impact of PBC symptoms and new instruments for assessing them. They also discuss data highlighting the importance of the current move toward normalisation of liver biomarkers and take a look at some early data on future therapies and therapeutic targets.<\/p>\n

Transcripts, with details of the presentations covered, are available for download.<\/p>\n

 <\/p>\n","protected":false},"author":{"id":1330,"first_name":"Melissa","last_name":"Turner","nickname":"melissa.turner@cor2ed.com","email":"melissa.turner@cor2ed.com"},"featured_media":101596,"menu_order":0,"template":"","labels":[61,74,67,43],"keywords":[],"class_list":["post-101508","programmes","type-programmes","status-publish","has-post-thumbnail","hentry","labels-liver","labels-primary-biliary-cholangitis","labels-rare-disease","labels-rare-liver-diseases"],"programme_info_project-code":"IP 23-07-02","programme_info_type":"podcast","programme_info_sub-type":"","programme_info_medical-affairs":"","programme_info_series":"yes","programme_info_series-uid":"","programme_info_series-number":"1","programme_info_multiple-media":"","programme_info_subtitle":"

PBC Highlights from EASL: Episode 1<\/p>","programme_info_supporter-disclaimer":"","programme_info_acknowledgement":"

Ipsen<\/p>","programme_info_learning-objetives":"","programme_info_pop-up":"","programme_info_pop-up-text":"","programme_info_pop-up-button-1":"","programme_info_pop-up-button-2":"","programme_therapeutic-areas_therapeutic-areas":["625"],"programme_connect_connect":"","programme_experts_experts":["92306","6597","101384","92456"],"programme_partnerships_partnerships":"","programme_accreditations_accreditations":["191663"],"programme_programmes_programmes":"","programme_connects_connects":"","programme_users_users":"","programme_medias_media_collection":"1","programme_medias_media_show_0":"","programme_medias_media_group_0":"","programme_medias_media_project-code_0":"","programme_medias_media_title_0":"PBC Highlights from EASL: Episode 1","programme_medias_media_subtitle_0":"","programme_medias_media_description_0":"","programme_medias_media_type_0":"castos","programme_medias_media_youtube_0":"","programme_medias_media_vimeo_0":"","programme_medias_media_castos_0":"1506005","programme_medias_media_castos-video_0":"","programme_medias_media_spotify_0":"11QLJ60R70aE76iFKbySBq","programme_medias_media_spotify-video_0":"","programme_medias_media_apple_0":"1000618596485","programme_medias_media_apple-video_0":"","programme_medias_media_google_0":"aHR0cHM6Ly9wZXJtYWxpbmsuY2FzdG9zLmNvbS9wb2RjYXN0LzI1Njk2L2VwaXNvZGUvMTUwNjAwNQ?sa=X&ved=0CAUQkfYCahcKEwjw55mm0vqBAxUAAAAAHQAAAAAQAg","programme_medias_media_google-video_0":"","programme_medias_media_url_0":"","programme_medias_media_scorm_0":"","programme_medias_media_file_0":"","programme_medias_media_duration_0":"30","programme_medias_media_overview_0":"","programme_medias_media_audio-transcript_0":"","programme_medias_media_additional-description_0":"","programme_medias_media_supporter-disclaimer_0":"","programme_medias_media_acknowledgement_0":"","programme_medias_media_learning-objetives_0":"","programme_medias_media_custom-description-title_0":"","programme_medias_media_custom-description-text_0":"","programme_medias_media_connect_0":"","programme_medias_media_experts_0":"","programme_medias_media_partnerships_0":"","programme_medias_media_connects_0":"","programme_medias_media_0_documents_collection":"1","programme_medias_media_0_documents_file_0":"111075","programme_medias_media_0_documents_button_0":"Ep. 1 - Transcript & Details","programme_medias_media_0_documents_file_1":"","programme_medias_media_0_documents_button_1":"","programme_medias_media_0_documents_file_2":"","programme_medias_media_0_documents_button_2":"","programme_medias_media_0_documents_file_3":"","programme_medias_media_0_documents_button_3":"","programme_medias_media_0_documents_file_4":"","programme_medias_media_0_documents_button_4":"","programme_medias_media_0_documents_file_5":"","programme_medias_media_0_documents_button_5":"","programme_medias_media_0_documents_file_6":"","programme_medias_media_0_documents_button_6":"","programme_medias_media_0_documents_file_7":"","programme_medias_media_0_documents_button_7":"","programme_medias_media_0_documents_file_8":"","programme_medias_media_0_documents_button_8":"","programme_medias_media_0_documents_file_9":"","programme_medias_media_0_documents_button_9":"","programme_medias_media_0_buttons_collection":"","programme_medias_media_0_buttons_text_0":"","programme_medias_media_0_buttons_url_0":"","programme_medias_media_0_buttons_text_1":"","programme_medias_media_0_buttons_url_1":"","programme_medias_media_0_buttons_text_2":"","programme_medias_media_0_buttons_url_2":"","programme_medias_media_0_buttons_text_3":"","programme_medias_media_0_buttons_url_3":"","programme_medias_media_0_buttons_text_4":"","programme_medias_media_0_buttons_url_4":"","programme_medias_media_0_buttons_text_5":"","programme_medias_media_0_buttons_url_5":"","programme_medias_media_0_buttons_text_6":"","programme_medias_media_0_buttons_url_6":"","programme_medias_media_0_buttons_text_7":"","programme_medias_media_0_buttons_url_7":"","programme_medias_media_0_buttons_text_8":"","programme_medias_media_0_buttons_url_8":"","programme_medias_media_0_buttons_text_9":"","programme_medias_media_0_buttons_url_9":"","programme_medias_media_0_social-media-url_collection":"","programme_medias_media_0_social-media-url_url_0":"","programme_medias_media_0_social-media-url_url_1":"","programme_medias_media_0_social-media-url_url_2":"","programme_medias_media_0_social-media-url_url_3":"","programme_medias_media_0_social-media-url_url_4":"","programme_medias_media_0_social-media-url_url_5":"","programme_medias_media_0_social-media-url_url_6":"","programme_medias_media_0_social-media-url_url_7":"","programme_medias_media_0_social-media-url_url_8":"","programme_medias_media_0_social-media-url_url_9":"","programme_medias_media_show_1":"","programme_medias_media_group_1":"","programme_medias_media_project-code_1":"","programme_medias_media_title_1":"PBC Highlights from EASL 2023: Episode 2","programme_medias_media_subtitle_1":"","programme_medias_media_description_1":"","programme_medias_media_type_1":"castos","programme_medias_media_youtube_1":"","programme_medias_media_vimeo_1":"","programme_medias_media_castos_1":"1506007","programme_medias_media_castos-video_1":"","programme_medias_media_spotify_1":"","programme_medias_media_spotify-video_1":"","programme_medias_media_apple_1":"","programme_medias_media_apple-video_1":"","programme_medias_media_google_1":"","programme_medias_media_google-video_1":"","programme_medias_media_url_1":"","programme_medias_media_scorm_1":"","programme_medias_media_file_1":"","programme_medias_media_duration_1":"22","programme_medias_media_overview_1":"","programme_medias_media_audio-transcript_1":"","programme_medias_media_additional-description_1":"

Clinical Takeaways<\/strong><\/h3>\r\n

 <\/p>\r\n